ZYUS Life Sciences Announces Closing of First Tranche of Non-Brokered Unit Offering

ZYUS Life Sciences Corporation has successfully closed the first tranche of its non-brokered unit offering, raising gross proceeds of C$200,000 by issuing 444,444 units at C$0.45 each. Each unit consists of one common share and one-half of a common share purchase warrant, with whole warrants exercisable at C$0.59 for 24 months. Insiders acquired all units in this tranche, and the offering has received conditional approval from the TSX Venture Exchange, pending final acceptance.